معرفی
Seojin Kim is an Assistant Professor of Management in the Strategy Group at Drexel University's LeBow College of Business. She holds a Ph.D. in Strategy and Entrepreneurship from the University of Maryland’s Robert H. Smith School of Business and brings prior industry experience from SK Telecom, IBM, and a Korean publishing firm into her academic work.
Education:
- Ph.D. in Strategy and Entrepreneurship, Robert H. Smith School of Business, University of Maryland
Her research centers on entrepreneurial strategy, innovation, and the evolution of nascent industries, particularly in healthcare technology domains such as prosthetics, diagnostics, and medical imaging. She investigates how individual and firm-level prior experiences shape strategic decisions under uncertainty, and how technological and regulatory environments influence innovation and market entry. Methodologically, she combines econometrics with rich historical and large-scale datasets, often employing quasi-experimental designs and textual analysis.
The recent articles highlight a consistent focus on innovation under institutional constraints, firm resilience during crises, and the interplay between public missions and private enterprise in industry formation. Her work spans healthcare innovation, regulatory dynamics, and strategic responses in emerging markets.
Scientific Awards and Recognition:
- Finalist, 2022 Industry Studies Association Dissertation Award
- Finalist, 2020 INFORMS/Organization Science Best Dissertation Proposal Competition
- Kauffman Knowledge Challenge Grant
- Strategy Research Foundation (SRF) Dissertation Grant
- 2024 SMJ Outstanding Reviewer Award (Strategic Management Society)
Dr. Kim has secured competitive research grants and actively contributes to the academic community through service as a reviewer for Strategic Management Journal. She collaborates with leading scholars such as Rajshree Agarwal, Rajshree Agarwal, and Ben Goldfarb, indicating an active research network and advisory role in ongoing projects. Her work-in-progress includes studies on medical device recalls, talent acquisition post-regulation, and IP rights in federally funded research, suggesting a robust future research agenda.
She is affiliated with multiple research platforms including Google Scholar, SSRN, and LinkedIn, and maintains an active scholarly presence. Her research bridges academic rigor with real-world applications in healthcare and innovation policy.
